Study of DR10624 for high triglycerides and carotid artery plaque
Part of Hormones & metabolism clinical trials.
This trial tests a new drug, DR10624, to see if it can lower high triglycerides and reduce plaque in the carotid artery (the main artery in your neck). It may help people with both conditions who are also overweight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a body mass index (BMI) of 24 or higher (overweight or obese).
- Your fasting triglyceride levels are between 1.7 and 5.7 mmol/L on two separate tests.
- You have at least one plaque in your carotid artery (confirmed by ultrasound).
- You are willing to follow lifestyle advice and stay on a stable routine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests an experimental drug called CS-121 for people with very high triglyceride levels that don't improve with standard treatments. It uses a new gene-editing approach to lower triglycerides and aims to reduce the risk of pancreatitis and other complications.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This early-phase trial tests an experimental drug called FXR0906 in healthy adults who have elevated triglycerides (a type of fat in the blood). It aims to see if the drug is safe and how it affects cholesterol and fat levels, which may help prevent heart disease.
Hear when a new Hypertriglyceridemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.